Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017 Opportunities, Product Types, Applications, Forecast to 2022

Request for a SAMPLE REPORT

Fill up your details below and get the sample report for FREE

 Published Date : Dec-2017   |    Format :PDF   |    Number of Pages : 137
This report studies the Viral Vectors and Plasmid DNA Manufacturing market status and outlook of global and major regions, from angles of players, regions, product types and end industries; this report analyzes the top players in global and major regions, and splits the Viral Vectors and Plasmid DNA Manufacturing market by product type and applications/end industries.

In the last several years, global market of Viral Vectors and Plasmid DNA Manufacturing developed rapidly, with an average growth rate of 28.05%. In 2016, global revenue of Viral Vectors and Plasmid DNA Manufacturing is nearly 250 M USD. 

The major players in global Viral Vectors and Plasmid DNA Manufacturing market include 
BioReliance
Cobra Biologics
Oxford BioMedica
UniQure
FinVector
MolMed
MassBiologics
Richter-Helm
FUJIFILM Diosynth Biotechnologies
Lonza
Aldevron
Eurogentec
Cell and Gene Therapy Catapult
Biovian
Brammer Bio
VGXI
PlasmidFactory

Geographically, this report is segmented into several key Regions, with revenue, Market Share and Growth Rate of Viral Vectors and Plasmid DNA Manufacturing in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
Asia-Pacific
South America
Middle East and Africa

On the basis of product, the Viral Vectors and Plasmid DNA Manufacturing market is primarily split into 
Plasmid DNA
Viral Vectors 


On the basis on the end users/applications, this report covers 
Cancers
Inherited Disorders
Viral Infections
Other

1 Viral Vectors and Plasmid DNA Manufacturing Market Overview	1
1.1 Viral Vectors and Plasmid DNA Manufacturing Product Overview	1
1.2 Viral Vectors and Plasmid DNA Manufacturing Segment by Types (Product Category)	1
1.2.1 Global Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Comparison by Types (2012-2022)	1
1.2.2 Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Types in 2016	2
1.2.3 Viral Vectors	3
1.2.4 Plasmid DNA	3
1.3 Global Viral Vectors and Plasmid DNA Manufacturing Segment by Applications	4
1.3.1 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Comparison by Applications (2012-2022)	4
1.3.2 Cancers	5
1.3.3 Inherited Disorders	6
1.3.4 Viral Infections	7
1.4 Global Viral Vectors and Plasmid DNA Manufacturing Market by Regions (2012-2022)	8
1.4.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size and Growth Comparison by Regions (2012-2022)	8
1.4.2 North America Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2012-2022)	9
1.4.3 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2012-2022)	10
1.4.4 Europe Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2012-2022)	11
1.4.5 South America Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2012-2022)	12
1.4.6 Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2012-2022)	13
1.5 Global Viral Vectors and Plasmid DNA Manufacturing Market Size (2012-2022)	14
2 Global Viral Vectors and Plasmid DNA Manufacturing Market Competition by Manufacturers/Brand	15
2.1 Global Viral Vectors Manufacturing Revenue and Share by Manufacturers (2016-2017)	15
2.2 Global Plasmid DNA Manufacturing Revenue and Share by Manufacturers (2016-2017)	17
2.3 Global Viral Vectors and Plasmid DNA Manufacturing Gross Margin by Manufacturers (2016-2017)	19
2.4 Manufacturers Viral Vectors and Plasmid DNA Manufacturing Headquarters, Established Date, Product Types	21
2.5 Viral Vectors and Plasmid DNA Manufacturing Market Competitive Situation and Trends	22
2.5.1 Viral Vectors and Plasmid DNA Manufacturing Market Concentration Rate	22
2.5.2 Viral Vectors and Plasmid DNA Manufacturing Market Share of Top 3 and Top 5 Manufacturers	23
2.5.3 Mergers & Acquisitions, Expansion	24
3 Global Viral Vectors and Plasmid DNA Manufacturing, Revenue by Regions (2012-2017)	27
3.1 Global Viral Vectors and Plasmid DNA Manufacturing Revenue and Market Share by Regions (2012-2017)	27
3.2 Global Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Profit, Cost and Gross Margin (2012-2017)	29
3.3 North America Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Profit, Cost and Gross Margin (2012-2017)	29
3.4 Europe Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Profit, Cost and Gross Margin (2012-2017)	30
3.5 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Profit, Cost and Gross Margin (2012-2017)	30
3.6 South America Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Profit, Cost and Gross Margin (2012-2017)	31
3.7 Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Profit, Cost and Gross Margin (2012-2017)	31
4 Global Viral Vectors and Plasmid DNA Manufacturing Revenue, Growth Trend by Types	32
4.1 Global Viral Vectors and Plasmid DNA Manufacturing Revenue and Market Share by Types (2012-2017)	32
4.2 Global Viral Vectors and Plasmid DNA Manufacturing Growth by Type (2012-2017)	34
5 Global Viral Vectors and Plasmid DNA Manufacturing Market Analysis by Applications	35
5.1 Global Viral Vectors and Plasmid DNA Manufacturing Revenue and Market Share by Applications (2012-2017)	35
5.2 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Growth Rate by Applications (2012-2017)	37
6 Analysis of Viral Vectors and Plasmid DNA Manufacturing Industry Key Manufacturers	38
6.1 BioReliance	38
6.1.1 Company Profile	38
6.1.2 Product Information	40
6.1.3 Revenue, Cost, Gross Profit and Gross Margin	40
6.2 Cobra Biologics	40
6.2.1 Company Profile	40
6.2.2 Product Information	42
6.2.3 Revenue, Cost, Gross Profit and Gross Margin	42
6.3 Oxford BioMedica	43
6.3.1 Company Profile	43
6.3.2 Product Information	44
6.3.3 Revenue, Cost, Gross Profit and Gross Margin	44
6.4 UniQure	45
6.4.1 Company Profile	45
6.4.2 Product Information	46
6.4.3 Revenue, Cost, Gross Profit and Gross Margin	46
6.5 FinVector	47
6.5.1 Company Profile	47
6.5.2 Product Information	48
6.5.3 Revenue, Cost, Gross Profit and Gross Margin	48
6.6 MolMed	49
6.6.1 Company Profile	49
6.6.2 Product Information	50
6.6.3 Revenue, Cost, Gross Profit and Gross Margin	51
6.7 MassBiologics	51
6.7.1 Company Profile	51
6.7.2 Product Information	52
6.7.3 Revenue, Cost, Gross Profit and Gross Margin	52
6.8 Richter-Helm	53
6.8.1 Company Profile	53
6.8.2 Product Information	54
6.8.3 Revenue, Cost, Gross Profit and Gross Margin	55
6.9 FUJIFILM Diosynth Biotechnologies	55
6.9.1 Company Profile	55
6.9.2 Product Information	56
6.9.3 Revenue, Cost, Gross Profit and Gross Margin	57
6.10 Lonza	57
6.10.1 Company Profile	57
6.10.2 Product Information	58
6.10.3 Revenue, Cost, Gross Profit and Gross Margin	59
6.11 Aldevron	59
6.11.1 Company Profile	59
6.11.2 Product Information	60
6.11.3 Revenue, Cost, Gross Profit and Gross Margin	60
6.12 Eurogentec	61
6.12.1 Company Profile	61
6.12.2 Product Information	62
6.12.3 Revenue, Cost, Gross Profit and Gross Margin	62
6.13 Cell and Gene Therapy Catapult	62
6.13.1 Company Profile	62
6.13.2 Product Information	64
6.13.3 Revenue, Cost, Gross Profit and Gross Margin	64
6.14 Biovian	64
6.14.1 Company Profile	64
6.14.2 Product Information	65
6.14.3 Revenue, Cost, Gross Profit and Gross Margin	66
6.15 Brammer Bio	66
6.15.1 Company Profile	66
6.15.2 Product Information	68
6.15.3 Revenue, Cost, Gross Profit and Gross Margin	68
6.16 VGXI	69
6.16.1 Company Profile	69
6.16.2 Product Information	70
6.16.3 Revenue, Cost, Gross Profit and Gross Margin	71
6.17 PlasmidFactory	71
6.17.1 Company Profile	71
6.17.2 Product Information	72
6.17.3 Revenue, Cost, Gross Profit and Gross Margin	73
7 Viral Vectors and Plasmid DNA Manufacturing Manufacturing Cost Analysis	74
7.1 Viral Vectors and Plasmid DNA Manufacturing Key Raw Materials Analysis	74
7.1.1 Key Raw Materials	74
7.1.2 Key Suppliers of Raw Materials	75
7.2 Proportion of Manufacturing Cost Structure	77
7.2.1 Raw Materials	77
7.2.2 Labor Cost Analysis	78
7.2.2.1 USA Labor Cost Analysis	78
7.2.2.2 Europe Labor Costs Analysis	79
7.2.2.3 Asia Labor Costs Analysis	81
7.2.3 Other Costs Analysis	82
7.2.3.1 USA Cost of Electricity Analysis	82
7.2.3.2 USA Water Cost Analysis	82
7.2.3.3 Europe Cost of Electricity Analysis	83
7.2.3.4 Europe Water Cost Analysis	84
7.2.3.5 China Cost of Electricity Analysis	85
7.2.3.6 China Water Cost Analysis	86
7.2.4 Manufacturing Expenses	86
7.3 Manufacturing Process Analysis of Viral Vectors and Plasmid DNA Manufacturing	87
8 Industrial Chain, Sourcing Strategy and Downstream Buyers	88
8.1 Viral Vectors and Plasmid DNA Manufacturing Industrial Chain Analysis	88
8.2 Upstream Raw Materials Sourcing	89
8.3 Downstream Buyers	89
9 Marketing Strategy Analysis, Distributors/Traders	92
9.1 Marketing Channel	92
9.1.1 Direct Marketing	92
9.1.2 Indirect Marketing	92
9.1.3 Marketing Channel Development Trend	93
9.2 Market Positioning	93
9.2.1 Pricing Strategy	93
9.2.2 Brand Strategy	94
9.2.3 Target Client	96
10 Market Effect Factors Analysis	97
10.1 Technology Progress in Related Industry	97
10.2 Consumer Needs/Customer Preference Change	98
10.3 Economic/Political Environmental Change	98
11 Global Viral Vectors and Plasmid DNA Manufacturing Market Forecast (2017-2022)	107
11.1 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Forecast (2017-2022)	107
11.2 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Forecast by Regions (2017-2022)	108
11.2.1 North America Viral Vectors and Plasmid DNA Manufacturing Revenue Forecast (2017-2022)	109
11.2.2 Europe Viral Vectors and Plasmid DNA Manufacturing and Revenue Forecast (2017-2022)	110
11.2.3 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue Forecast (2017-2022)	111
11.2.4 South America Viral Vectors and Plasmid DNA Manufacturing Revenue Forecast (2017-2022)	112
11.2.5 Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Revenue Forecast (2017-2022)	113
11.3 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Forecast by Type (2017-2022)	113
11.4 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Forecast by Application (2017-2022)	114
12 Research Findings and Conclusion	116
13 Methodology and Data Source	117
13.1 Methodology/Research Approach	117
13.1.1 Research Programs/Design	117
13.1.2 Market Size Estimation	118
13.1.3 Market Breakdown and Data Triangulation	119
13.2 Data Source	120
13.2.1 Secondary Sources	120
13.2.2 Primary Sources	121
13.3 Disclaimer	122
13.4 Author List	123


List of Tables and Figures

Figure Product Picture of Viral Vectors and Plasmid DNA Manufacturing	1
Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) and Growth Rate Comparison by Types (Product Category) (2012-2022)	1
Figure Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Types in 2016	2
Figure Product Picture of Viral Vectors	3
Figure Product Picture of Plasmid DNA	3
Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) Comparison by Applications (2012-2022)	4
Figure Global Viral Vectors and Plasmid DNA Manufacturing Sales Market Share by Applications in 2016	4
Figure Cancers Examples	5
Figure Inherited Disorders Examples	6
Figure Viral Infections Examples	7
Figure Global Viral Vectors and Plasmid DNA Manufacturing Market Size (M USD) Comparison and Growth by Regions (2012-2022)	8
Table Global Market Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) Comparison by Regions 2012-2022	8
Figure North America Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) and Growth Rate (2012-2022)	9
Figure Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) and Growth Rate (2012-2022)	10
Figure Europe Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) and Growth Rate (2012-2022)	11
Figure South America Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) and Growth Rate (2012-2022)	12
Figure Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) and Growth Rate (2012-2022)	13
Figure Global Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) Status and Outlook (2012-2022)	14
Table Global Viral Vectors Revenue (M USD) of Key Manufacturers (2016-2017)	15
Table Global Viral Vectors Manufacturing Revenue Share by Manufacturers (2016-2017)	15
Figure 2016 Viral Vectors Manufacturing Revenue Share by Manufacturers	16
Figure 2017 Viral Vectors Manufacturing Revenue Share by Manufacturers	17
Table Global Plasmid DNA Manufacturing Revenue (M USD) by Manufacturers (2016-2017)	17
Table Global Plasmid DNA Manufacturing Revenue Share by Manufacturers (2016-2017)	18
Figure 2016 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Manufacturers	18
Figure 2016 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Manufacturers	19
Table Global Market Viral Vectors and Plasmid DNA Manufacturing Gross Margin of Key Manufacturers (2016-2017)	19
Figure Global Market Viral Vectors and Plasmid DNA Manufacturing Gross Margin of Key Manufacturers in 2016	20
Table Manufacturers Viral Vectors and Plasmid DNA Manufacturing Headquarters and Established Date	21
Table Manufacturers Viral Vectors and Plasmid DNA Manufacturing Product Category	21
Figure Viral Vectors and Plasmid DNA Manufacturing Market Concentration Rate	22
Figure Viral Vectors and Plasmid DNA Manufacturing Market Share of Top 3 Manufacturers	23
Figure Viral Vectors and Plasmid DNA Manufacturing Market Share of Top 5 Manufacturers	24
Table Mergers & Acquisitions, Expansion	24
Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) by Regions (2012-2017)	27
Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Regions (2012-2017)	27
Figure Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Regions (2012-2017)	28
Figure 2016 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Regions	28
Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Gross Profit (M USD), Cost (M USD) and Gross Margin (2012-2017)	29
Table North America Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Gross Profit (M USD), Cost (M USD) and Gross Margin (2012-2017)	29
Table Europe Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Gross Profit (M USD), Cost (M USD) and Gross Margin (2012-2017)	30
Table Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Gross Profit (M USD), Cost (M USD) and Gross Margin (2012-2017)	30
Table South America Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Gross Profit (M USD), Cost (M USD) and Gross Margin (2012-2017)	31
Table Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Gross Profit (M USD), Cost (M USD) and Gross Margin (2012-2017)	31
Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) by Types (2012-2017)	32
Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Types (2012-2017)	32
Figure Revenue Share of Viral Vectors and Plasmid DNA Manufacturing by Types (2012-2017)	33
Figure 2016 Revenue Market Share of Viral Vectors and Plasmid DNA Manufacturing by Types	33
Figure Global Viral Vectors and Plasmid DNA Manufacturing Growth by Type (2012-2017)	34
Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) by Applications (2012-2017)	35
Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Applications (2012-2017)	35
Figure Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Applications (2012-2017)	36
Figure Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Applications in 2016	36
Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue Growth Rate by Applications (2012-2017)	37
Figure Global Viral Vectors and Plasmid DNA Manufacturing Revenue Growth Rate by Applications (2012-2017)	37
Table BioReliance Company Profile	38
Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of BioReliance 2016-2017	40
Table Cobra Biologics Company Profile	40
Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of Cobra Biologics	42
Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Cobra Biologics 2016-2017	42
Table Oxford BioMedica Company Profile	43
Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of Oxford BioMedica	44
Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Oxford BioMedica 2016-2017	44
Table UniQure Company Profile	45
Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of UniQure 2016-2017	46
Table FinVector Company Profile	47
Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of FinVector	48
Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of FinVector 2016-2017	48
Table MolMed Company Profile	49
Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of MolMed	50
Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of MolMed 2016-2017	51
Table MassBiologics Company Profile	51
Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of MassBiologics 2016-2017	52
Table Richter-Helm Company Profile	53
Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of Richter-Helm	54
Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Richter-Helm 2016-2017	55
Table FUJIFILM Diosynth Biotechnologies Company Profile	55
Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of FUJIFILM Diosynth Biotechnologies	56
Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of FUJIFILM Diosynth Biotechnologies 2016-2017	57
Table Lonza Company Profile	57
Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of Lonza	58
Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Lonza 2016-2017	59
Table Aldevron Company Profile	59
Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of Aldevron	60
Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Aldevron 2016-2017	60
Table Eurogentec Company Profile	61
Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of Eurogentec	62
Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Eurogentec 2016-2017	62
Table Cell and Gene Therapy Catapult Company Profile	62
Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of Cell and Gene Therapy Catapult	64
Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Cell and Gene Therapy Catapult 2016-2017	64
Table Biovian Company Profile	64
Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of Biovian	65
Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Biovian 2016-2017	66
Table Brammer Bio Company Profile	66
Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of Brammer Bio	68
Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Brammer Bio 2016-2017	68
Table VGXI Company Profile	69
Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of VGXI	70
Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of VGXI 2016-2017	71
Table PlasmidFactory Company Profile	71
Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of PlasmidFactory	72
Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of PlasmidFactory 2016-2017	73
Table Key Raw Materials of Viral Vectors and Plasmid DNA Manufacturing	74
Table Key Suppliers of Raw Materials	75
Figure Manufacturing Cost Structure of Viral Vectors and Plasmid DNA Manufacturing	77
Figure USA Labor Cost Analysis 2012-2016	78
Figure Cost of Employing a Factory Worker	79
Figure 2016 Estimated Labour Costs for the Whole Economy in Europe	80
Figure Monthly Minimum Wages in Asia 2016	81
Figure China Labor Costs 2013-2016	81
Table Average Price of Electricity to Ultimate Customers 2007-2016	82
Figure Electricity Prices for Household Consumers in 2016	83
Figure Summary of the Driving Assumptions	85
Figure Industrial Electric Rates 2016 (PER KWH)	85
Figure Manufacturing Process Analysis of Viral Vectors and Plasmid DNA Manufacturing	87
Figure Viral Vectors and Plasmid DNA Manufacturing Industrial Chain Analysis	88
Table Major Buyers of Viral Vectors and Plasmid DNA Manufacturing	89
Figure Setting Pricing Policy	94
Figure Global GDP Growth Rate for 2016	99
Figure US GDP 2006-2016 (Billion USD)	100
Figure US CPI Change 2016-2017	100
Figure EU GDP 2006-2016 (Billion USD)	101
Figure EU CPI Change 2012-2016	101
Figure Germany GDP 2006-2016 (Billion USD)	102
Figure Germany CPI Change 2016-2017	102
Figure UK GDP 2006-2016 (Billion USD)	102
Figure UK CPI Change 2016-2017	103
Figure Italy GDP 2006-2016 (Billion USD)	103
Figure Italy CPI Change 2016-2017	104
Figure Japan GDP 2006-2016 (Billion USD)	104
Figure Japan CPI Change 2012-2016	105
Figure China GDP 2006-2016 (Billion USD)	105
Figure China CPI Change 2016-2017	106
Figure Global Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) and Growth Rate Forecast (2017-2022)	107
Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) Forecast by Regions (2017-2022)	108
Figure Global Viral Vectors and Plasmid DNA Manufacturing Market Share Forecast by Regions (2017-2022)	108
Figure North America Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) and Growth Rate Forecast (2017-2022)	109
Figure Europe Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) and Growth Rate Forecast (2017-2022)	110
Figure Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) and Growth Rate Forecast (2017-2022)	111
Figure South America Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) and Growth Rate Forecast (2017-2022)	112
Figure Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) and Growth Rate Forecast (2017-2022)	113
Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) Forecast by Type (2017-2022)	113
Figure Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share Forecast by Type (2017-2022)	114
Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) Forecast by Application (2017-2022)	114
Figure Global Viral Vectors and Plasmid DNA Manufacturing Forecast by Application (2017-2022)	115



Latest News

25-Feb-2019 | Medical Devices

Launch Of Symjepi Epinephrine Syringe To Boost The Syringe Market Growth In US

A rising burden of chronic diseases has been observed all across the world, which, in turn, has elevated the usage of syringes. Overall, the global syringe market is anticipated to observe vigorous ...

25-Feb-2019 | Electrical & Electronic Device

Launch Of Xiaomi Set-Top Box To Power The Global 4K Set-Top Box Market

While smart TVs are turning out to be much more widespread these days, a number of consumers still choose to opt for normal TVs and then employ smart streaming set top box with them. Popular choice ...

13-Feb-2019 | Software

Bioinspired Artificial Bug Eye Creation Is A Baton For Global Autonomous Car Market

After looking at the different eye lens structures of the animals and humans, the researchers have decided on creating a sharp image using its design. The compound eyes of the bugs are currently be ...

13-Feb-2019 | Consumer Goods & Retailing

Cafe X’s $12 Million “Seed-1” Round To Boost The Global Coffee Market

Cafe X, a company engaged in building robot baristas, is about to raise a $12 Million “Seed-1” round. Recently, Crunchbase News broke the story when it came across regulatory f ...

05-Feb-2019 | Chemicals & Materials

Clinically Produced Cells Change The Horizon Of Global Bone Cement And Glue Market

The group of researchers from the New York Stem Cell Foundation Research Institute published an article in Stem Cell Research and Therapy where the details regarding the clinical ...